论文部分内容阅读
用血滤片测量17-羟孕酮(17-OHP)含量的方法广泛用于先天性肾上腺增生症(CAH)的筛查。如果在妊娠中有早产的可能,则在胎儿出生前用类固醇治疗来促进肺部成熟,但这样会抑制胎儿肾上腺,还会影响对这种先天性肾上腺增生症的筛查。笔者对160名胎龄为25-35周新生儿,在其生后72-96 h,用血滤片法测量其17-OHP,将其中50名出生前没有接受类固醇治疗的新生儿与110名出生前接受类固醇治疗者进行比较。1个疗程的类固醇疗法是:地塞米松12 mg,间隔24 h 静脉注射2次。其中30例接受了半个疗程治疗,45例
The method of measuring the 17-hydroxyprogesterone (17-OHP) content with a blood filter is widely used for the screening of congenital adrenal hyperplasia (CAH). If there is a possibility of prematurity during pregnancy, steroid treatment is used to promote lung maturation prior to birth, but this inhibits the fetus’s adrenal gland and also affects screening for this congenital adrenal hyperplasia. The author of 160 gestational age of 25-35 weeks of newborns, after their 72-96 h, using blood filter method to measure the 17-OHP, of which 50 were born before the birth of steroids and 110 newborns Before birth were steroid treated for comparison. A course of steroid therapy is: dexamethasone 12 mg, 24 h intravenously 2 times. 30 of them received half a course of treatment, 45 cases